{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:11Z","timestamp":1787237831705,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":6178,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1111\/j.1600-6143.2005.01143.x","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T07:11:33Z","timestamp":1132297893000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Antifibrotic Agents for Liver Disease"],"prefix":"10.1016","volume":"6","author":[{"given":"E.","family":"Albanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2005.01143.x_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States.","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation.","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival.","volume":"281","author":"Adams","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years.","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1053\/jlts.2003.50248","article-title":"The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.","volume":"9","author":"Gane","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.TP.0000101738.27552.9D","article-title":"Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.","volume":"77","author":"Neumann","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation.","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation.","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1089-3261(05)70168-9","article-title":"Hepatic fibrosis. Pathogenesis and principles of therapy.","volume":"5","author":"Albanis","year":"2001","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of hepatic fibrosis and therapeutic implications.","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0168-8278(01)00218-5","article-title":"Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.","volume":"35","author":"Kweon","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib16","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking.","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840190323","article-title":"Expression of platelet-derived growth factor in a model of acute liver injury.","volume":"19","author":"Pinzani","year":"1994","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells.","volume":"21","author":"Pinzani","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0168-8278(98)80269-9","article-title":"Molecular regulation of hepatic fibrogenesis.","volume":"29","author":"Olaso","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0014-5793(89)81804-6","article-title":"Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells.","volume":"257","author":"Bachem","year":"1989","journal-title":"Febs Lett"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1053\/he.2000.6126","article-title":"Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.","volume":"31","author":"Dooley","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2001-17551","article-title":"Hepatic blood flow regulation by stellate cells in normal and injured liver.","volume":"21","author":"Rockey","year":"2001","journal-title":"Seminars in Liver Disease"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI117769","article-title":"Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.","volume":"95","author":"Rockey","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of stellate cells.","volume":"21","author":"Benyon","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2001-17557","article-title":"Stellate cell behavior during resolution of liver injury.","volume":"21","author":"Iredale","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.","volume":"102","author":"Iredale","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(00)80067-7","article-title":"Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells.","volume":"32","author":"Gentilini","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/jhep.2001.20677","article-title":"Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton.","volume":"33","author":"Tangkijvanich","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib30","first-page":"194","article-title":"Reversing hepatic fibrosis.","volume":"8","author":"Friedman","year":"2002","journal-title":"Sci Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.36.3.437","article-title":"Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.","volume":"36","author":"Gilmore","year":"1995","journal-title":"Gut"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0016-5085(90)91167-5","article-title":"A 21-year experience with major hemorrhage after percutaneous liver biopsy.","volume":"99","author":"McGill","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2004-823103","article-title":"Liver biopsy sampling in chronic viral hepatitis.","volume":"24","author":"Guido","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/BF02235164","article-title":"Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.","volume":"16","author":"Soloway","year":"1971","journal-title":"Am J Dig Dis"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archinte.1979.03630430043014","article-title":"Sampling variability on percutaneous liver biopsy.","volume":"139","author":"Abdi","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.","volume":"1","author":"Maharaj","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib40","first-page":"51","article-title":"The variation of pathological changes in the liver evaluated by double biopsies.","volume":"87","author":"Baunsgaard","year":"1979","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib41","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib42","first-page":"660","article-title":"Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.","volume":"42","author":"Rockey","year":"1994","journal-title":"J Investig Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/5593","article-title":"Hepatocyte growth factor gene therapy of liver cirrhosis in rats.","volume":"5","author":"Ueki","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib44","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/bbrc.2002.6385","article-title":"Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride.","volume":"291","author":"Kon","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/gast.1997.v113.pm9322499","article-title":"A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.","volume":"113","author":"Houglum","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510290108","article-title":"Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats [see comments].","volume":"29","author":"Shimizu","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib50","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0168-8278(98)80136-0","article-title":"Protease inhibitors suppress TGF-beta generation by hepatic stellate cells.","volume":"29","author":"Okuno","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/jhep.2000.9109","article-title":"Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.","volume":"32","author":"Nakamura","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib52","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","article-title":"In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.","volume":"96","author":"George","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib53","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/hy1201.100589","article-title":"Role of the renin-angiotensin system in vascular diseases: expanding the field.","volume":"38","author":"Ruiz-Ortega","year":"2001","journal-title":"Hypertension"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/snep.2002.34725","article-title":"The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease.","volume":"22","author":"Brown","year":"2002","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000060162","article-title":"Angiotensin II, TGF-beta and renal fibrosis.","volume":"135","author":"Gaedeke","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins.","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.1979.tb01669.x","article-title":"Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.","volume":"9","author":"Arroyo","year":"1979","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib58","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells.","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib59","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0168-8278(02)00104-6","article-title":"Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.","volume":"37","author":"Yoshiji","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0168-8278(02)00307-0","article-title":"Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and\/or portal hypertension.","volume":"37","author":"Croquet","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib63","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","article-title":"Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.","volume":"14","author":"Boffa","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib64","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI7997","article-title":"Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.","volume":"105","author":"Yu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/mthe.2000.0210","article-title":"Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.","volume":"2","author":"Salgado","year":"2000","journal-title":"Mol Ther"},{"key":"10.1111\/j.1600-6143.2005.01143.x_bib66","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","article-title":"Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.","volume":"121","author":"Wright","year":"2001","journal-title":"Gastroenterology"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2005.01143.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522025369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522025369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2005.01143.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:37:39Z","timestamp":1761626259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522025369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1600613522025369"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01143.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifibrotic Agents for Liver Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01143.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}